Gujarat Kidney And Super Speciality Share Price
161.05-2.54 (-1.55%)
+54.06% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSPNSE
MAXHEALTHNSE
MANIPALHOSNSE
ASTERDMNSE
FORTISNSE
NHNSE
MEDANTANSE
LALPATHLABNSE
KIMSNSE
AGARWALEYENSE
GKSLNSE
Gujarat Kidney And Super Speciality Share Price
161.05-2.54 (-1.55%)
+54.06% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 104% |
| - | - | - | 77% |
| - | - | - | - |
| 54% | 54% | 81% | 12% |
Peer Comparison
Symbol
APOLLOHOSP
MAXHEALTH
MANIPALHOS
ASTERDM
FORTIS
NH
MEDANTA
LALPATHLAB
KIMS
AGARWALEYE
GKSL
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 8,440 | ₹121067 Cr | 57.94 | 40.39 | 207.67 | ₹1942 Cr |
| 895.5 | ₹85955 Cr | 62.26 | 4.26 | 19.36 | ₹1442 Cr |
| 645.2 | ₹85953 Cr | 96.33 | 1.96 | 11.95 | ₹892 Cr |
| 681.35 | ₹58742 Cr | 184.33 | 0.31 | 6.76 | ₹388 Cr |
| 785.55 | ₹57377 Cr | 54.75 | 3.53 | 20.1 | ₹1042 Cr |
| 1,870.6 | ₹37545 Cr | 43.72 | 14.73 | 71.14 | ₹806 Cr |
| 1,325.8 | ₹34919 Cr | 62.78 | 5.91 | 29.85 | ₹556 Cr |
| 1,925.7 | ₹31682 Cr | 58.46 | 10.11 | 42.51 | ₹505 Cr |
| 731.75 | ₹30276 Cr | 148.2 | 1.04 | 12.74 | ₹241 Cr |
| 511 | ₹16301 Cr | 109.87 | 1.43 | 13.88 | ₹133 Cr |
| 161.05 | ₹1293 Cr | 81.63 | 0.66 | 2.66 | ₹15 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| ₹34 Cr | ₹31 Cr | ₹23 Cr | ₹13 Cr | ₹15 Cr | ₹10 Cr | ₹12 Cr | ₹9 Cr |
| ₹69 L | ₹71 L | ₹6 L | ₹9 L | ₹80,000 | ₹5 L | ₹5 L | ₹5 L |
| ₹35 Cr | ₹31 Cr | ₹23 Cr | ₹13 Cr | ₹15 Cr | ₹10 Cr | ₹12 Cr | ₹9 Cr |
| ₹27 Cr | ₹26 Cr | ₹18 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹8 Cr | ₹5 Cr |
| ₹9 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹9 Cr | ₹3 Cr | ₹5 Cr | ₹5 Cr |
| ₹66 L | ₹82 L | ₹60 L | ₹28 L | ₹18 L | ₹16 L | ₹17 L | ₹16 L |
| ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹7 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr |
| ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹5 Cr | ₹1 Cr | ₹3 Cr | ₹3 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| — | — | — | — | — |
| ₹16 Cr | ₹11 Cr | ₹20 L | ₹20 L | ₹20 L |
| ₹0 | ₹0 | ₹9 Cr | ₹0 | ₹0 |
| ₹237 Cr | ₹15 Cr | ₹2 Cr | ₹17 L | ₹18 L |
| ₹237 Cr | ₹15 Cr | ₹2 Cr | ₹17 L | ₹18 L |
| ₹253 Cr | ₹26 Cr | ₹11 Cr | ₹37 L | ₹38 L |
| ₹2 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 |
| ₹77 L | ₹2 Cr | ₹2 Cr | ₹0 | ₹0 |
| ₹1 Cr | ₹50 L | ₹0 | ₹0 | ₹0 |
| -₹3 Cr | -₹68 L | -₹3 L | -₹4 L | -₹4 L |
| ₹13 Cr | ₹4 Cr | ₹4 Cr | ₹0 | ₹0 |
| ₹77 L | ₹45 L | ₹26 L | ₹0 | ₹0 |
| ₹13 Cr | ₹6 Cr | ₹5 Cr | -₹4 L | -₹4 L |
| — | — | — | — | — |
| ₹8 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr |
| ₹6 Cr | ₹16 Cr | ₹2 Cr | ₹3 L | ₹3 L |
| ₹13 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 |
| ₹19 L | ₹2 Cr | ₹39 L | ₹0 | ₹48,000 |
| ₹28 Cr | ₹22 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr |
| ₹295 Cr | ₹55 Cr | ₹20 Cr | ₹4 Cr | ₹4 Cr |
| ₹0 | ₹3 L | ₹0 | ₹0 | ₹0 |
| ₹16 Cr | ₹4 Cr | ₹2 Cr | ₹0 | ₹0 |
| — | — | — | — | — |
| ₹152 Cr | ₹37 Cr | ₹14 Cr | ₹0 | ₹3 Cr |
| ₹23 Cr | ₹6 Cr | ₹32 L | ₹0 | ₹57 L |
| ₹129 Cr | ₹31 Cr | ₹14 Cr | ₹0 | ₹3 Cr |
| ₹12 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹12 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹48 Cr | ₹13 L | ₹6 L | ₹0 | ₹0 |
| ₹2 Cr | ₹2 Cr | ₹7 L | ₹3 Cr | ₹0 |
| ₹191 Cr | ₹33 Cr | ₹14 Cr | ₹3 Cr | ₹3 Cr |
| — | — | — | — | — |
| ₹2 Cr | ₹68 L | ₹27 L | ₹0 | ₹0 |
| ₹39 Cr | ₹15 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr |
| ₹56 Cr | ₹3 Cr | ₹1 Cr | ₹35,000 | ₹34,000 |
| ₹77 L | ₹87 L | ₹90 L | ₹0 | ₹0 |
| ₹7 Cr | ₹2 Cr | ₹18 L | ₹0 | ₹0 |
| ₹105 Cr | ₹22 Cr | ₹7 Cr | ₹1 Cr | ₹1 Cr |
| ₹77 Cr | ₹15 L | ₹2 Cr | -₹2 Cr | -₹2 Cr |
| ₹295 Cr | ₹55 Cr | ₹20 Cr | ₹4 Cr | ₹4 Cr |
| ₹32 | ₹5 | ₹87 | ₹19 | ₹19 |
| ₹32 | ₹5 | ₹0 | ₹0 | ₹0 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| ₹21 Cr | ₹13 Cr | ₹2 Cr | -₹62,000 | ₹14 L |
| ₹6 Cr | ₹4 Cr | -₹23 L | ₹0 | ₹57 L |
| -₹22 Cr | -₹35 L | -₹65 L | ₹1 L | -₹61 L |
| ₹6 Cr | ₹16 Cr | ₹1 Cr | ₹50,000 | ₹10 L |
| -₹4 Cr | ₹14 Cr | ₹1 Cr | ₹1,000 | ₹22,000 |
| -₹214 Cr | -₹18 Cr | ₹22 L | ₹0 | ₹0 |
| ₹228 Cr | ₹6 Cr | -₹47 L | ₹0 | ₹0 |
| ₹11 Cr | ₹2 Cr | ₹97 L | ₹1,000 | ₹22,000 |
| ₹3 Cr | ₹97 L | ₹35,000 | ₹34,000 | ₹12,000 |
| ₹13 Cr | ₹3 Cr | ₹97 L | ₹35,000 | ₹34,000 |
Fundamental Ratios
Consolidated
Standalone
No results found
Gujarat Kidney And Super Speciality Share Price
161.05-2.54 (-1.55%)
+54.06% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 4
Bearish signals: 5 out of 9 oscillators
RSI
34.20Sell
STOCH %K
2.43Buy
MACD Level(12,26)
-3.06Sell
Ultimate Oscillator
30.05Sell
Aroon Oscillator
52.00Buy
BOP
-0.85Sell
CCI
-154.33Buy
Williams %R
-97.57Buy
Momentum
-24.80Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 7 out of 9 moving averages
EMA 9
170.13Sell
SMA 9
171.02Sell
EMA 21
175.20Sell
SMA 21
180.32Sell
EMA 50
170.76Sell
SMA 50
174.62Sell
EMA 200
134.71Buy
SMA 200
134.37Buy
WMA 20
175.35Sell
Pivot
Pivot
Classic
Resistance 5
189.08
Resistance 4
182.80
Resistance 3
176.52
Resistance 2
170.24
Resistance 1
166.92
Pivot
163.96
Support 1
160.64
Support 2
157.68
Support 3
151.40
Support 4
145.12
Support 5
138.84
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Gujarat Kidney And Super Speciality Share Price
161.05-2.54 (-1.55%)
+54.06% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| 71.45% | 71.45% | 71.45% | 71.45% | 71.45% |
| 6.52% | 4.89% | 4.89% | 10.47% | 13.09% |
| 0.25% | 0.56% | 0.56% | 1.67% | 2.85% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 21.78% | 23.10% | 23.10% | 16.41% | 12.61% |
Bulk & block deals
Name
Nexus Global Opportunities Fund
Natvarsinh T Chavda
Natvarsinh T Chavda
Qe Securities Llp
Qe Securities Llp
Natvarsinh T Chavda
Natvarsinh T Chavda
Alphagrep Securities Private Limited
Priyal Bohra
Natvarsinh T Chavda
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 26 Oct 2026 | Sell | 7.81 Cr | ₹178 | 4.39 L | Bulk | 0.556365 | NSE |
| 07 Oct 2026 | Sell | 9.34 Cr | ₹192.19 | 4.86 L | Bulk | 0.616601 | NSE |
| 07 Oct 2026 | Purchase | 8.90 Cr | ₹188.97 | 4.71 L | Bulk | 0.597576 | NSE |
| 05 Oct 2026 | Sell | 8.13 Cr | ₹190.48 | 4.27 L | Bulk | 0.54166 | NSE |
| 05 Oct 2026 | Purchase | 8.54 Cr | ₹192.61 | 4.43 L | Bulk | 0.562308 | NSE |
| 05 Oct 2026 | Sell | 13.86 Cr | ₹192.11 | 7.21 L | Bulk | 0.914939 | NSE |
| 05 Oct 2026 | Purchase | 13.64 Cr | ₹189.10 | 7.21 L | Bulk | 0.914939 | NSE |
| 01 Oct 2026 | Purchase | 12.16 Cr | ₹198.29 | 6.13 L | Bulk | 0.777987 | NSE |
| 01 Oct 2026 | Purchase | 7.82 Cr | ₹195.84 | 4 L | Bulk | 0.50676 | NSE |
| 01 Oct 2026 | Purchase | 5.88 Cr | ₹194.40 | 3.02 L | Bulk | 0.3834 | NSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Gujarat Kidney And Super Speciality Share Price
161.05-2.54 (-1.55%)
+54.06% past 1 Year
Gujarat Kidney and Super Speciality operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary (which are surgical services) and tertiary care (which are
Corporate Actions
Date
Type
Details
Company details
Gujarat Kidney And Super Speciality Share Price
161.05-2.54 (-1.55%)
+54.06% past 1 Year
Corporate filings & documents
Announcements
Annual reports
No annual reports found
Concalls & investor presentations
No presentations found
Gujarat Kidney And Super Speciality Share Price
161.05-2.54 (-1.55%)
+54.06% past 1 Year
News
Gujarat Kidney and Super Speciality inform about newspaper publication
Equity
GKSL
Guj. Kidney & Super reports Profit after tax of 1.37 Crores, in the March 2026 quarter
Equity
GKSL
Gujarat Kidney and Super Speciality rises on getting nod to incorporate wholly owned subsidiary
Equity
GKSL
Gujarat Kidney Q3 FY26 Results: Revenue Growth Accelerates Amid Margin Compression
Equity
GKSL
Guj. Kidney & Super reports Profit after tax of 2.33 Crores, in the December 2025 quarter
Equity
GKSL
GKSL Board Approves 51% Stake Acquisitions in Patel Pharmacy and Patel Hospital for Rs 12.50 Crores
Equity
GKSL
Gujarat Kidney And Super Speciality: Board Greenlights 49% Stake Purchase In Harmony Medicare
Equity
GKSL
Gujarat Kidney and Super Speciality informs about outcome of board meeting
Equity
GKSL
Gujarat Kidney and Super Speciality to acquire Parekhs Hospital
Equity
GKSL
Gujarat Kidney and Super Speciality Shares List at 6% Premium on BSE at Rs 120.75 vs Issue Price Rs 114.
Broader Market
GKSL
Guj. Kidney & Super reports Profit after tax of 2.30 Crores, in the September 2025 quarter
Equity
GKSL